OncoMatch/Clinical Trials/NCT04513808
Total Intravenous Anesthesia and Recurrence Free Survival
Is NCT04513808 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies multiple treatments including Propofol-based total intravenous anesthesia and Sevoflurane intravenous anesthesia for esophageal cancer.
Treatment: Propofol-based total intravenous anesthesia · Sevoflurane intravenous anesthesia — The investigators propose to compare recurrence-free survival in patients having potentially curative (Stages 1-3) surgery for esophageal cancer who will be randomly assigned to propofol-based total intravenous anesthesia or sevoflurane-based balanced general anesthesia.
Check if I qualifyExtracted eligibility criteria
Cancer type
Esophageal Carcinoma
Performance status
ASA 0–3
Prior therapy
Cannot have received: surgery
Exception: diagnostic biopsies
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify